CD47 and cancer: Platelet membrane surface is also equipped with “self‐recognized” proteins CD47, thus endowing platelet membrane‐derived nanodrugs with immune evasion ability and extended plasma half‐life.[63] In recent years, it was reported that platelets have a crucial association with cancer metastatic progression based on the active interactions between platelets and tumor cells.